Pharmacological Stabilization of Mast Cells Abrogates Late Thrombotic Events Induced by Diesel Exhaust Particles in Hamsters
Open Access
- 21 September 2004
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 110 (12), 1670-1677
- https://doi.org/10.1161/01.cir.0000142053.13921.21
Abstract
Background— Particulate air pollution is associated with cardiovascular diseases and myocardial infarction (MI). Methods and Results— We investigated the relationship between airway inflammation and thrombosis 24 hours after intratracheal (IT) instillation of diesel exhaust particles (DEP; 50 μg/hamster). Mild thrombosis was induced in the femoral vein by endothelial injury, and the consequences of airway inflammation on thrombogenicity were studied via online video microscopy. Lung inflammation and histamine analysis in bronchoalveolar lavage (BAL) and plasma were performed after pretreatment with dexamethasone (DEX) or sodium cromoglycate (SC). DEP induced airway inflammation and histamine release in BAL and in plasma, and increased thrombosis, without elevating plasma von Willebrand factor (vWF) levels. The IT instillation of 400-nm positively charged polystyrene particles (500 μg/hamster), serving as particles that do not penetrate into the circulation, equally produced airway inflammation, histamine release, and enhanced thrombosis. Histamine in plasma resulted from basophil activation. Intraperitoneal (IP) pretreatment with DEX (5 mg/kg) abolished the DEP-induced histamine increase in BAL and plasma and abrogated airway inflammation and thrombogenicity. The IT pretreatment with DEX (0.5 mg/kg) showed a partial but parallel inhibition of all of these parameters. Pretreatment with SC (40 mg/kg, IP) strongly inhibited airway inflammation, thrombogenicity, and histamine release. Conclusions— Our results are compatible with the triggering of mast cell degranulation and histamine release by DEP. Histamine plays an initial central role in airway inflammation, further release of histamine by circulating basophils, and peripheral thrombotic events. Antiinflammatory pretreatment can abrogate the peripheral thrombogenicity by preventing histamine release from mast cells.This publication has 39 references indexed in Scilit:
- Cardiovascular Damage by Airborne Particles: Are Diabetics More Susceptible?Epidemiology, 2002
- The Role of Mast Cells in the Pathophysiology of AsthmaThe New England Journal of Medicine, 2002
- Dexamethasone inhibits maturation, cytokine production and FcεRI expression of human cord blood‐derived mast cellsClinical & Experimental Allergy, 2002
- Histamine-Induced Production of Interleukin-6 and Interleukin-8 by Human Coronary Artery Endothelial Cells Is Enhanced by Endotoxin and Tumor Necrosis Factor-αMicrovascular Research, 2001
- Synergistic interaction of adrenaline and histamine in human platelet aggregation is mediated through activation of phospholipase, map kinase and cyclo-oxygenase pathwaysPharmacological Research, 2000
- Silica-Induced Pulmonary Inflammation in Rats: Activation of NF-κB and Its Suppression by DexamethasoneBiochemical and Biophysical Research Communications, 1998
- Role of H1 receptors and P-selectin in histamine-induced leukocyte rolling and adhesion in postcapillary venules.JCI Insight, 1994
- Immunoendocrine Interactions and AutoimmunityThe New England Journal of Medicine, 1990
- Histamine is an Intracellular Messenger Mediating Platelet AggregationScience, 1989
- Myocardial infarction and histamine releaseInflammation Research, 1986